Parmax Pharma Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2020. For the quarter, the company reported total income of INR 104,740,946 against INR 69,476,821 a year ago. Profit for the period was INR 15,368,428 against INR 10,169,246 a year ago. Basic EPS was INR 4.11 against INR 2.72 a year ago. For the nine months, the company reported total income of INR 188,787,000 against INR 166,133,011 a year ago. Profit for the period was INR 10,576,194 against INR 13,121,895 a year ago. Basic EPS was INR 2.83 against INR 3.51 a year ago.